do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline SGLT2 and in Diabetic Kidney Disease: Evolving Evidence and Clinical Application Were DPP-4 inhibitors the original
Description
The most common side effects of GLP-1 receptor agonists are gastrointestinal, including nausea, diarrhea, and vomiting, affecting 40-70% of patients
These agents delay gastric emptying which makes patients feel fuller for longer
Hydrophobic interactions between Phe 9 and Y152 1.47 and L141 1.36 anchor the peptide to GLP-1R in both a conformer 1-like structure (beginning of the video) and a conformer 2-like structure (end of the video) during the simulation
Diabetes, Obesity & Metabolism
